openPR Logo
Press release

Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising Ophthalmic Disease Burden and Advances in Diagnostic Imaging

12-11-2025 07:08 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Ophthalmology PACS Market

Ophthalmology PACS Market

The global Ophthalmology PACS (Picture Archiving and Communication System) Market is poised for strong expansion over the next decade as the industry continues transitioning toward digital, AI-enabled ophthalmic imaging management solutions. According to recent market assessments, the global Ophthalmology PACS market valued at US$ 167.8 Mn in 2023 is projected to grow at a CAGR of 7.3% from 2024 to 2034, ultimately reaching US$ 359.8 Mn by the end of 2034.

Access important conclusions and data points from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56127

Market Overview: Ophthalmology PACS is an advanced medical imaging technology dedicated to the storage, retrieval, management, and distribution of ophthalmic diagnostic images and patient data. These platforms integrate imaging modalities such as fundus photography, optical coherence tomography (OCT), ultrasound biomicroscopy, fluorescein angiography, and more. Increasing digitization of healthcare, the rise of teleophthalmology, and continuous improvements in imaging systems are redefining clinical workflows.

Advanced PACS platforms now incorporate AI-driven analytics, predictive modeling, and cloud-based architectures, enabling faster diagnosis, superior clinical decision-making, and collaborative care-especially important in managing diseases such as diabetic retinopathy, glaucoma, cataracts, age-related macular degeneration (AMD), and other retinal disorders.

Key Market Growth Drivers

1. Growing Prevalence of Ophthalmic Diseases
A global rise in cataracts, AMD, glaucoma, and diabetic retinopathy continues to boost demand for high-resolution ophthalmic imaging and long-term data management solutions. Aging demographics and increased diabetes prevalence further contribute to rapid diagnostic imaging expansion.

2. Technological Advancements in Diagnostic Imaging
Innovations in PET, SPECT, CT, MRI, sonography, and advanced ophthalmic imaging technologies are reshaping diagnosis and treatment planning. AI, VR-based surgical preparation tools, wearable diagnostics, 3D imaging, and automated screening systems are increasingly integrated with PACS platforms.

3. Digitization of Healthcare & Cloud Adoption
Growing investment in electronic health records (EHR), teleophthalmology, and cloud-based PACS systems is accelerating global adoption. Cloud PACS allows remote access, real-time sharing, and improved interoperability across care settings.

4. Enhanced Clinical Workflows and Predictive Analytics
PACS platforms now offer automated reporting, advanced visualization, workflow optimization, and interoperability with EMR systems, supporting faster and more accurate patient management.

Market Challenges & Opportunities

Key Challenges
• High installation and maintenance costs limit adoption in low- and middle-income countries.
• Interoperability issues between PACS and legacy imaging systems.
• Data privacy and cybersecurity risks associated with cloud-based imaging services.
• Lack of trained professionals fluent in AI-enabled imaging systems.

Major Opportunities
• Rapid expansion of tele-ophthalmology in rural and underserved regions.
• Growing potential for AI-based automated disease grading (e.g., diabetic retinopathy).
• Rising demand for cost-efficient PACS platforms in emerging markets.
• Increasing government investments in healthcare digitization.
• Cloud-based PACS platforms enabling scalable subscription models, enhancing affordability.

Analysis of Key Players - Strategic Initiatives

Leading companies are investing in AI integration, cloud-based architecture, R&D innovations, mergers & acquisitions, and geographic expansion. Several prominent players have adopted batch normalization techniques and machine learning algorithms to enhance disease severity grading.

Key Strategies Include:
• Mergers & acquisitions to expand product portfolios and extend global reach.
• Collaborative partnerships with hospitals and eye care centers to deploy advanced PACS solutions.
• R&D investment focused on AI-powered diagnostic workflows.
• Product upgrades to offer enhanced interoperability with EMRs and imaging devices.
• Cost-efficient solutions tailored to developing markets.

Recent Developments

• May 2022: OMNY Health partnered with ophthalmology practices to develop a real-world data ecosystem for clinical research and enhanced patient outcomes.

• April 2022: ZEISS Medical Technology secured FDA approval for its QUATERA 700 phaco technology, enabling a digitally integrated surgical workflow.

• July 2021: Intelerad Medical Systems collaborated with LifeBridge Health for cloud-based managed imaging services.

• 2020: EyeMD EMR Healthcare Systems unveiled EyeMD EMR 2.0 at the AAO Virtual Conference, combining EMR, PM, and PACS capabilities.

Buy this Premium Research Report to stay informed with key insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=56127<ype=S

Investment Landscape & ROI Outlook

The ophthalmology PACS market presents a strong investment landscape characterized by:
High Return on Investment (ROI) Potential
• Growing patient population and imaging volumes.
• Long-term clinical demand for image lifecycle management.
• Increasing integration of AI, automation, and predictive diagnostics.
• Expanding applications in teleophthalmology and mobile screening units.
Favorable Conditions for Investors
• High market stability due to essential nature of ophthalmic diagnostics.
• Rising global investment in healthcare digitization and imaging infrastructure.
• Strong opportunities in the Asia Pacific and Latin American markets due to modernization initiatives.
The long-term ROI outlook remains robust as ophthalmology shifts toward advanced digital imaging ecosystems and remote diagnostic platforms.

Market Segmentation

By Product Type
• Integrated PACS
• Standalone PACS

By Delivery Model
• On-premise
• Web/Cloud-based

By End User
• Hospitals
• Ophthalmology Clinics
• Ambulatory Surgery Centers
• Eye Research Institutes and Others

By Region
• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Spain)
• Asia Pacific (China, India, Japan, Australia & New Zealand)
• Latin America (Brazil, Mexico)
• Middle East & Africa (South Africa, GCC)

North America led the market in 2023 due to high healthcare spending and strong adoption of advanced imaging technologies. Asia Pacific is emerging as a fast-growing region driven by modernization of healthcare systems, increased medical tourism, and rising incidence of eye disorders.

Why Buy This Report?

• Comprehensive analysis of global market trends, drivers, and challenges.
• In-depth segmentation with regional breakdowns and forecasts.
• Detailed competitive landscape with profiles of major market players.
• Insights into technological advancements and emerging opportunities.
• Access to strategic recommendations for investors and stakeholders.
• Includes both quantitative (US$ Mn) and qualitative evaluation.
• Delivered in easily accessible PDF + Excel formats with customization options.

FAQs

1. How big was the global ophthalmology PACS market in 2023?
It was valued at US$ 167.8 Mn in 2023.

2. What is the expected growth rate of the market from 2024 to 2034?
The market is projected to grow at a CAGR of 7.3% during the forecast period.

3. What are the major factors driving market growth?
Rising prevalence of ophthalmic diseases and continuous technological advancements in diagnostic imaging.

4. Which end-user segment held the largest market share in 2023?
Ophthalmology clinics accounted for the largest share due to high imaging volumes and PACS adoption.

5. Which region dominated the market in 2023?
North America dominated the global landscape owing to better healthcare infrastructure and strong digitization efforts.

Explore Latest Research Reports by Transparency Market Research:

Mesotherapy Market: https://www.transparencymarketresearch.com/mesotherapy-market.html

Cochlear Implants Market: https://www.transparencymarketresearch.com/cochlear-implants-market.html

Digital Thermometers Market: https://www.transparencymarketresearch.com/digital-thermometer-market.html

Polycystic Ovarian Syndrome Treatment Market: https://www.transparencymarketresearch.com/polycystic-ovarian-syndrome-treatment-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising Ophthalmic Disease Burden and Advances in Diagnostic Imaging here

News-ID: 4312126 • Views:

More Releases from Transparency Market Research

Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Rising Ocular Disease Burden and Advancements in Eye Surgery
Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Ris …
The global Ophthalmic Sutures Market is experiencing significant momentum as demand surges for improved ophthalmic surgical outcomes amid increasing incidences of ocular disorders worldwide. According to the latest industry assessment, the market, valued at US$ 629.0 million in 2023, is projected to expand at a CAGR of 6.5% between 2024 and 2034, ultimately reaching US$ 1.3 billion by 2034. This comprehensive press release provides an in-depth examination of market size, trends,
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 2031 Amid Rising Incidence of Cataracts and Glaucoma
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 20 …
The global Ophthalmology Surgical Devices Market is poised for steady expansion, driven by rising demand for advanced surgical systems, increasing prevalence of cataracts and glaucoma, and accelerating adoption of minimally invasive techniques. The market was valued at US$ 8.1 billion in 2022 and is projected to reach US$ 12.1 billion by 2031, expanding at a CAGR of 4.7% from 2023 to 2031. Unlock crucial data and key findings from our Report
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by Rising Addiction Rates and Government Initiatives
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by R …
The global Opioid Use Disorders (OUD) Market is set for strong expansion over the next decade, rising from US$ 3.2 billion in 2023 to an estimated US$ 8.8 billion by 2034, according to the latest industry assessment. The market is projected to grow at a CAGR of 9.9% from 2024 to 2034, supported by increasing government funding, rising public awareness, and the escalating prevalence of opioid addiction across all major
Optical Microscopes Market to Reach USD 4.1 Bn by 2031 Amid Rising R&D Investments and Rapid Technological Advancements
Optical Microscopes Market to Reach USD 4.1 Bn by 2031 Amid Rising R&D Investmen …
The global Optical Microscopes Market is poised for robust expansion over the next decade, supported by increasing applications in biotechnology, medical diagnostics, and advanced scientific research. According to the latest industry analysis, the market-valued at US$ 2.5 billion in 2022-is projected to rise at a CAGR of 5.7% from 2023 to 2031, ultimately reaching US$ 4.1 billion by 2031. Growing demand for early disease detection, a surge in R&D funding in

All 5 Releases


More Releases for PACS

Vendor Neutral Archive & PACS Market - Driving Connected Care: VNA & PACS Enhanc …
Newark, New Castle, USA - new report, titled Vendor Neutral Archive & PACS Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Vendor Neutral Archive & PACS market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Vendor Neutral Archive & PACS market.
PACS Market : Cloud-based PACS Will Cross US$ 1090.9 Mn by 2026
The global PACS market is segmented on the basis of deployment, components, business mode, end-use, and region. By deployment, PACS market is segmented into web-based PACS, cloud-based PACS and on-premise. Moreover, by components market is categorized into imaging modalities, secured network, and workstation and archives. On the basis of business mode, PACS market is fragmented into enterprise and departmental. Further PACS market end-users are hospitals, clinic imaging, dental practices, imaging
04-19-2017 | Health & Medicine
TMR
PACS and RIS Market: Asia Pacific PACS and RIS Market to Lead to Most Promising …
The picture archiving and communication system (PACS) and radiology information system (RIS) market is extremely consolidated, with the top five companies accounting for a share of over 61% in 2015. Transparency Market Research finds that GE Healthcare, Philips Healthcare, McKesson Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers have significantly contributed to the global market over the years by providing an extra advantage to customers at a reasonable price. “In contrast to
03-30-2017 | Health & Medicine
TMR
PACS and RIS Market: Cloud-based PACS and RIS to Witness Most Promising Growth
The picture archiving and communication system (PACS) and radiology information system (RIS) market is extremely consolidated, with the top five companies accounting for a share of over 61% in 2015. Transparency Market Research finds that GE Healthcare, Philips Healthcare, McKesson Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers have significantly contributed to the global market over the years by providing an extra advantage to customers at a reasonable price. “In contrast to
PACS and RIS Market Opportunity Analysis; Adoption of Cloud based PACS by Health …
Driven by the technological advancements in the medical and healthcare industry encouraged by governments across the world, the global market for picture archiving and communication systems (PACS) and radiology information systems (RIS) are likely to witness substantial growth over the forthcoming years. According to Transparency Market Research (TMR), the total opportunity offered by the worldwide PACS and RIS market was US$2.2 bn in 2015. Expanding at a healthy CAGR of 7.0%
PACS and RIS Market Opportunity Analysis 2024; Adoption of Cloud based PACS by H …
The opportunity in the global PACS and RIS market stood at US$2.2 bn in 2015 and, rising at a 7.0% CAGR during the forecast period, is estimated to be worth US$3.9 bn by 2024. The picture archiving and communication system (PACS) and radiology information system (RIS) market is extremely consolidated, with the top five companies accounting for a share of over 61% in 2015. Transparency Market Research finds that GE Healthcare,